# 바이오스페이스 일일 뉴스 리포트 - 2025년 12월 03일


## 주요 헤드라인

1. **Imvax Heads to FDA With 6-Month Survival Gain in Glioblastoma, Despite Endpoint Miss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/imvax-heads-to-fda-with-6-month-survival-gain-in-glioblastoma-despite-endpoint-miss>

2. **Imvax Heads to FDA With 6-Month Survival Gain in Glioblastoma, Despite Endpoint Miss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/imvax-heads-to-fda-with-6-month-survival-gain-in-glioblastoma-despite-endpoint-miss>

3. **I Remember Aduhelm. The Return of Roche in Alzheimer’s Is a Turning Point (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/i-remember-aduhelm-the-return-of-roche-in-alzheimers-is-a-turning-point>

4. **Roche Is Back in Alzheimer’s as Latest Antibody Clears Amyloid Plaques (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/roche-is-back-in-alzheimers-as-latest-antibody-clears-amyloid-plaques>

5. **ACIP To Discuss Hep B, Childhood Vaccine Schedule Under New Chair Who Linked COVID Shots to Cancer (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/acip-to-discuss-hep-b-childhood-vaccine-schedule-under-new-chair-who-linked-covid-shots-to-cancer>

6. **Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biotechs-secure-alternative-fill-finish-capacity-amid-scrutiny-of-novo-site>

7. **Biotechs Secure Alternative Fill/Finish Capacity Amid Scrutiny of Novo Site (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biotechs-secure-alternative-fill-finish-capacity-amid-scrutiny-of-novo-site>


---
*2025년 12월 03일 바이오스페이스 뉴스 피드에서 생성된 리포트*